SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Forbion Growth Sponsor FEAC I B.V.
(Last) (First) (Middle)
C/O FORBION EUROPEAN ACQUISITION CORP.
4001 KENNETT PIKE, SUITE 302
(Street)
WILMINGTON DE 19807
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Forbion European Acquisition Corp. [ FRBNU ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Ordinary Shares 10/30/2023 D 1,373,496 D (1) 0 I See Footnotes(2)(4)(5)(6)(7)
Class A Ordinary Shares 10/30/2023 D 2,000,000 D (1) 0 I See Footnotes(3)(4)(5)(6)(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (Right to Buy) $11.5 10/30/2023 D(9) 731,619 (8) (8) Class A Ordinary Shares 731,619 (9) 0 I See Footnotes(2)(4)(5)(6)(7)
Warrant (Right to Buy) $11.5 10/30/2023 D(9) 666,666 (8) (8) Class A Ordinary Shares 666,666 (9) 0 I See Footnotes(3)(4)(5)(6)(7)
1. Name and Address of Reporting Person*
Forbion Growth Sponsor FEAC I B.V.
(Last) (First) (Middle)
C/O FORBION EUROPEAN ACQUISITION CORP.
4001 KENNETT PIKE, SUITE 302
(Street)
WILMINGTON DE 19807
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Forbion Growth Opportunities Fund I Cooperatief U.A.
(Last) (First) (Middle)
C/O FORBION EUROPEAN ACQUISITION CORP.
4001 KENNETT PIKE, SUITE 302
(Street)
WILMINGTON DE 19807
(City) (State) (Zip)
1. Name and Address of Reporting Person*
Forbion Growth Management B.V.
(Last) (First) (Middle)
C/O FORBION EUROPEAN ACQUISITION CORP.
4001 KENNETT PIKE, SUITE 302
(Street)
WILMINGTON DE 19807
(City) (State) (Zip)
Explanation of Responses:
1. On October 31, 2023, in connection with the consummation of the Issuer's initial business combination, Class A Ordinary Shares were exchanged, on a one-for-one basis, for Class A common shares ("New enGene Shares") of enGene Holdings, Inc., a corporation incorporated under the laws of Canada ("New enGene"), which will be the parent company of the combined operating business following the consummation of initial business combination, as described in more detail in that certain Business Combination Agreement between the Issuer, enGene Inc. and enGene Holdings Inc., dated May 16, 2023 (the "Business Combination Agreement").
2. Reflects shares held by Forbion Growth Sponsor FEAC I B.V. (the "Sponsor"). The Sponsor is controlled by a four-person Board of Managers comprised of J.M Bos, C. Lesser, S. Slootweg and W.S.J. Joustra (the "Sponsor Board"). All voting and dispositive decisions with respect to the shares held by the Sponsor are made by a majority vote of the Sponsor Board.
3. Reflects shares held by Forbion Growth Opportunities Fund I cooperatief U.A. ("Forbion Cooperatief").
4. Forbion Cooperatief wholly owns the Sponsor. Forbion Growth Management B.V. is the sole director of Forbion Cooperatief and exercises voting and investment power through its investment committee (the "Management Investment Committee"), consisting of S. Slootweg, van Osch, G. J. Mulder, V. van Houten, D.A.F. Kersten, N.L. Luneborg, W.S.J. Joustra and J.M. Bos. None of the members of the Management Investment Committee has individual voting and investment power with respect to the securities reported herein.
5. Sponsor and Forbion Cooperatief may be deemed to have shared voting and investment power over the shares held by the Sponsor. Forbion Management may be deemed to share voting and investment power (i) with Forbion Cooperatief over the shares held by Forbion Cooperatief and (ii) with Forbion Cooperatief and, indirectly, the Sponsor, over the shares held by the Sponsor.
6. Under the so-called "rule of three," if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, none of the individuals is deemed a beneficial owner of the entity's securities. Accordingly, because none of the members of the Sponsor Board or the Management Investment Committee has individual voting or investment control over any of the Class A Ordinary Shares or Class B Ordinary Shares reported herein, no member of the Sponsor Board or the Management Investment Committee is deemed to have or share beneficial ownership of such shares.
7. Each Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of its pecuniary interest therein.
8. Each warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, and first becomes exercisable 30 days after the consummation of the Issuer's initial business combination. The warrants expire five years following the Issuer's initial business combination. The warrants also expire if the Issuer fails to consummate the initial business combination within 24 months from the Issuer's initial public offering.
9. On October 31, 2023, in connection with the Issuer's initial business combination, each warrant was assumed by New enGene and converted into a warrant entitling the holder thereof to purchase one New enGene Share at a price of $11.50 per share, as described in more detail in the Business Combination Agreement
/s/ Fobion Growth Sponsor FEAC I B.V., By: Sander Slootweg, Director, and Wouter Joustra, its Director 10/31/2023
/s/ Forbion Growth Opportunities Fund I Cooperatief U.A., By: Sander Slootweg, on behalf of Forbion Growth Management B.V., Director and Wouter Joustra, on behalf of Forbion Growth Management B.V., Director 10/31/2023
/s/ Forbion Growth Management B.V., By: Sander Slootweg, Director, and Wouter Joustra, its Director 10/31/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Forbion European Acquisi... (NASDAQ:FRBNU)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Forbion European Acquisi... Charts.
Forbion European Acquisi... (NASDAQ:FRBNU)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Forbion European Acquisi... Charts.